Not Tagged
Not Tagged
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'biomarker']
great discussion by jonathan riess regarding the egfrm nsclc landscape. definitely we need three things to move forward: better biomarkers, less toxicity and clinical research/drug development. we are currently focusing on the latter. #asco23 #lcsm
Husband, Father. Medical Oncologist and Researcher focused in Thoracic Oncology.  Views are my own. Member of @latenightonc - the best podcast in oncology!